| http://dbpedia.org/ontology/abstract
|
CRISPR Therapeutics AG is a Swiss–American … CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. In fiscal year 2021, the company had revenues of $915 million, with net income of $378 million. By the end of the same year, the number of employees stood at 473. As of December 2021, the company had a market capitalization of over $6 billion. CRISPR Therapeutics' investors include German chemical company Bayer. The company operates R&D in Cambridge, Massachusetts.rates R&D in Cambridge, Massachusetts.
, CRISPR Therapeutics AG ist ein Schweizer B … CRISPR Therapeutics AG ist ein Schweizer Biotechnologieunternehmen mit Hauptsitz in Zug. Im Geschäftsjahr 2019 erzielte das Unternehmen einen Umsatz von 289,59 Millionen US-Dollar, bei einem Ergebnis nach Steuern von 66,86 Millionen US-Dollar. Die Anzahl der Mitarbeiter lag zum selben Zeitpunkt bei 304 Personen. Anfang 2021 kam das Unternehmen auf eine Marktkapitalisierung von über 13 Milliarden US-Dollar. Zu den Investoren von CRISPR Therapeutics gehört auch das deutsche Chemieunternehmen Bayer AG.h das deutsche Chemieunternehmen Bayer AG.
|
| http://dbpedia.org/ontology/assets
|
2.75E9
|
| http://dbpedia.org/ontology/equity
|
2.4E9
|
| http://dbpedia.org/ontology/formerName
|
Inception Genomics
|
| http://dbpedia.org/ontology/foundedBy
|
http://dbpedia.org/resource/Emmanuelle_Charpentier +
|
| http://dbpedia.org/ontology/foundingYear
|
2013
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/Zug +
, http://dbpedia.org/resource/Switzerland +
|
| http://dbpedia.org/ontology/netIncome
|
3.78E8
|
| http://dbpedia.org/ontology/numberOfEmployees
|
473
|
| http://dbpedia.org/ontology/operatingIncome
|
3.74E8
|
| http://dbpedia.org/ontology/revenue
|
9.15E8
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/CRISPR_Therapeutics_logo.svg?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/ontology/wikiPageID
|
66323247
|
| http://dbpedia.org/ontology/wikiPageLength
|
6604
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1116369804
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:2016_initial_public_offerings +
, http://dbpedia.org/resource/Category:2013_establishments_in_Switzerland +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_2013 +
, http://dbpedia.org/resource/Food_and_Drug_Administration +
, http://dbpedia.org/resource/CRISPR_gene_editing +
, http://dbpedia.org/resource/Editas_Medicine +
, http://dbpedia.org/resource/Emmanuelle_Charpentier +
, http://dbpedia.org/resource/Vertex_Pharmaceuticals +
, http://dbpedia.org/resource/Category:Swiss_companies_established_in_2013 +
, http://dbpedia.org/resource/Public_company +
, http://dbpedia.org/resource/Jennifer_Doudna +
, http://dbpedia.org/resource/Zug +
, http://dbpedia.org/resource/Beta_thalassemia +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/European_Medicines_Agency +
, http://dbpedia.org/resource/Sickle_cell_disease +
, http://dbpedia.org/resource/Cambridge%2C_Massachusetts +
, http://dbpedia.org/resource/Bayer_AG +
, http://dbpedia.org/resource/Category:Companies_based_in_Zug +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_Switzerland +
, http://dbpedia.org/resource/Nobel_Prize_in_Chemistry +
, http://dbpedia.org/resource/Orphan_drug +
, http://dbpedia.org/resource/Intellia_Therapeutics +
, http://dbpedia.org/resource/Category:Genomics_companies +
, http://dbpedia.org/resource/Switzerland +
|
| http://dbpedia.org/property/assets
|
2.75E9
|
| http://dbpedia.org/property/equity
|
2.4E9
|
| http://dbpedia.org/property/formerName
|
Inception Genomics
|
| http://dbpedia.org/property/founders
|
http://dbpedia.org/resource/Emmanuelle_Charpentier +
, Rodger Novak
, Shaun Foy
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/isin
|
CH0334081137
|
| http://dbpedia.org/property/keyPeople
|
Samarth Kulkarni
|
| http://dbpedia.org/property/location
|
http://dbpedia.org/resource/Switzerland +
, http://dbpedia.org/resource/Zug +
|
| http://dbpedia.org/property/logo
|
File:CRISPR Therapeutics logo.svg
|
| http://dbpedia.org/property/logoSize
|
200
|
| http://dbpedia.org/property/name
|
CRISPR Therapeutics AG
|
| http://dbpedia.org/property/netIncome
|
3.78E8
|
| http://dbpedia.org/property/numEmployees
|
473
|
| http://dbpedia.org/property/operatingIncome
|
3.74E8
|
| http://dbpedia.org/property/revenue
|
9.15E8
|
| http://dbpedia.org/property/tradedAs
|
NASDAQ:CRSP
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:R +
, http://dbpedia.org/resource/Template:Use_dmy_dates +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Start_date_and_age +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Increase +
, http://dbpedia.org/resource/Template:URL +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Biotechnology_companies_of_Switzerland +
, http://dbpedia.org/resource/Category:2013_establishments_in_Switzerland +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_2013 +
, http://dbpedia.org/resource/Category:Companies_based_in_Zug +
, http://dbpedia.org/resource/Category:Swiss_companies_established_in_2013 +
, http://dbpedia.org/resource/Category:2016_initial_public_offerings +
, http://dbpedia.org/resource/Category:Genomics_companies +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Nasdaq +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/CRISPR_Therapeutics?oldid=1116369804&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/CRISPR_Therapeutics_logo.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/CRISPR_Therapeutics +
|
| http://xmlns.com/foaf/0.1/name
|
CRISPR Therapeutics AG
|
| owl:sameAs |
http://www.wikidata.org/entity/Q104480207 +
, http://de.dbpedia.org/resource/CRISPR_Therapeutics +
, http://dbpedia.org/resource/CRISPR_Therapeutics +
, https://global.dbpedia.org/id/FML6z +
, http://fa.dbpedia.org/resource/%DA%A9%D8%B1%DB%8C%D8%B3%D9%BE%D8%B1_%D8%AA%D8%B1%D8%A7%D9%BE%DB%8C%D9%88%D8%AA%DB%8C%DA%A9%D8%B3 +
|
| rdf:type |
http://dbpedia.org/ontology/Agent +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/ontology/Company +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://dbpedia.org/ontology/Organisation +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://schema.org/Organization +
, http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
|
| rdfs:comment |
CRISPR Therapeutics AG ist ein Schweizer B … CRISPR Therapeutics AG ist ein Schweizer Biotechnologieunternehmen mit Hauptsitz in Zug. Im Geschäftsjahr 2019 erzielte das Unternehmen einen Umsatz von 289,59 Millionen US-Dollar, bei einem Ergebnis nach Steuern von 66,86 Millionen US-Dollar. Die Anzahl der Mitarbeiter lag zum selben Zeitpunkt bei 304 Personen. Anfang 2021 kam das Unternehmen auf eine Marktkapitalisierung von über 13 Milliarden US-Dollar. Zu den Investoren von CRISPR Therapeutics gehört auch das deutsche Chemieunternehmen Bayer AG.h das deutsche Chemieunternehmen Bayer AG.
, CRISPR Therapeutics AG is a Swiss–American … CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. In fiscal year 2021, the company had revenues of $915 million, with net income of $378 million. By the end of the same year, the number of employees stood at 473. As of December 2021, the company had a market capitalization of over $6 billion. CRISPR Therapeutics' investors include German chemical company Bayer. The company operates R&D in Cambridge, Massachusetts.rates R&D in Cambridge, Massachusetts.
|
| rdfs:label |
CRISPR Therapeutics
|
